Acropolis Investment Management, LLC

Position in MRK — Merck & Co., Inc.

CIK 1318601 ST. LOUIS, MO

Position in MRK

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$1,769,188

+$7,782 QoQ

Shares Held

13,768

-6.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.65%

of 13F equity value

Holder Rank

#1,674

of 3,768 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Acropolis Investment Management, LLC holds $13,272,644 across 8 Drug Manufacturers - General names. MRK ranks #4 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	20,115	$5,108,606
2	LLY	ELI LILLY & Co	2,014	$2,415,652
3	ABBV	AbbVie Inc.	7,039	$1,771,293
4	MRK	Merck & Co., Inc. This page	13,768	$1,769,188
5	BMY	Bristol Myers Squibb Co	17,771	$1,023,965
6	AMGN	Amgen Inc	1,487	$538,472
7	PFE	Pfizer Inc	18,379	$442,566
8	GILD	Gilead Sciences, Inc.	1,606	$202,902

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,769,188	13,768	-6.0%	Shares	Sole	2026-07-16
2026-03-31	$1,761,406	14,643	-2.7%	Shares	Sole	2026-04-09
2025-12-31	$1,584,057	15,049	-4.7%	Shares	Sole	2026-01-14
2025-09-30	$1,325,506	15,793	+5.0%	Shares	Sole	2025-10-07
2025-06-30	$1,190,803	15,043	-9.4%	Shares	Sole	2025-07-14
2025-03-31	$1,490,464	16,605	-3.4%	Shares	Sole	2025-04-17
2024-12-31	$1,710,658	17,196	-5.9%	Shares	Sole	2025-01-14
2024-06-30	$2,261,207	18,265	+9.7%	Shares	Sole	2024-07-16
2024-03-31	$2,196,175	16,644	+0.1%	Shares	Sole	2024-04-17
2023-12-31	$1,812,893	16,629	-4.4%	Shares	Sole	2024-01-16
2023-09-30	$1,790,403	17,391	-0.2%	Shares	Sole	2023-10-11
2023-06-30	$2,010,324	17,422	-0.9%	Shares	Sole	2023-07-13
2023-03-31	$1,870,123	17,578	+2.7%	Shares	Sole	2023-04-11
2022-12-31	$1,899,907	17,124	—	Shares	Sole	2023-01-11
No filing history on record for this holder in this stock.